These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34756160)

  • 1. Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains.
    Huo Y; Yang J; Liu P; Cui B; Wang C; Liu S; Dong F; Yan X; Bian L; Gao F; Wu X; Zhou J; Cheng T; Li X; Mao Q; Liang Z
    Hum Vaccin Immunother; 2021 Dec; 17(12):5334-5347. PubMed ID: 34756160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a pseudovirus-based assay for measuring neutralizing antibodies against Coxsackievirus A10.
    Li K; Dong F; Cui B; Cui L; Liu P; Ma C; Zheng H; Wu X; Liang Z
    Hum Vaccin Immunother; 2020 Jun; 16(6):1434-1440. PubMed ID: 31851566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
    Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
    Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice.
    Dai W; Xiong P; Zhang X; Liu Z; Chen J; Zhou Y; Ye X; Zhang C
    Antiviral Res; 2019 Apr; 164():139-146. PubMed ID: 30817941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge.
    Shen C; Liu Q; Zhou Y; Ku Z; Wang L; Lan K; Ye X; Huang Z
    Vaccine; 2016 Sep; 34(41):5005-5012. PubMed ID: 27562093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems.
    Bian L; Gao F; Mao Q; Sun S; Wu X; Liu S; Yang X; Liang Z
    Expert Rev Anti Infect Ther; 2019 Apr; 17(4):233-242. PubMed ID: 30793637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
    Fang CY; Liu CC
    Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model.
    Jin WP; Lu J; Zhang XY; Wu J; Wei ZN; Mai JY; Qian SS; Yu YT; Meng SL; Wang ZJ; Shen S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the biological characteristics of three CV-A10 clones adaptively cultured on Vero cells.
    Zhao H; Yang T; Yue L; Li H; Xie T; Xiang H; Wang J; Wei X; Zhang Y; Xie Z
    J Med Virol; 2022 Aug; 94(8):3820-3828. PubMed ID: 35437759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.
    Lim H; In HJ; Lee JA; Sik Yoo J; Lee SW; Chung GT; Choi YK; Chung JK; Cho SJ; Lee JW
    Vaccine; 2018 Jun; 36(24):3445-3452. PubMed ID: 29739716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and cellular immunogenicity and efficacy of a coxsackievirus A10 vaccine in mice.
    An HH; Li M; Liu RL; Wu J; Meng SL; Guo J; Wang ZJ; Qian SS; Shen S
    Emerg Microbes Infect; 2023 Dec; 12(1):e2147022. PubMed ID: 36373411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a neutralizing linear epitope within the VP1 protein of coxsackievirus A10.
    Zhu H; Liu X; Wu Y; He Y; Zheng H; Liu H; Liu Q
    Virol J; 2022 Dec; 19(1):203. PubMed ID: 36457099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular epidemiology of hand-foot-mouth disease associated pathogen Coxsackievirus A10 identified in Fujian province, 2011-2014].
    Chen W; Weng Y; He W; Zhu Y; Zhang Y; Huang M; Xie J; Zheng K; Yan Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Apr; 37(4):563-7. PubMed ID: 27087227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic analysis of coxsackievirus A10 in rhesus macaques.
    Duan S; Yang F; Li Y; Zhao Y; Shi L; Qin M; Liu Q; Jin W; Wang J; Chen L; Zhang W; Li Y; Zhang Y; Zhang J; Ma S; He Z; Li Q
    Virol Sin; 2022 Aug; 37(4):610-618. PubMed ID: 35777657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of coxsackievirus A10 strains isolated from children with hand, foot, and mouth disease.
    Zhang J; Xu D; Liu H; Zhang M; Feng C; Cong S; Sun H; Yang Z; Ma S
    J Med Virol; 2022 Feb; 94(2):601-609. PubMed ID: 34387895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive profiling and characterization of cellular microRNAs in response to coxsackievirus A10 infection in bronchial epithelial cells.
    Hu Y; Wang L; Zhong M; Zhao W; Wang Y; Song J; Zhang Y
    Virol J; 2022 Jul; 19(1):120. PubMed ID: 35864512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
    Mao Q; Wang Y; Bian L; Xu M; Liang Z
    Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.
    Zhang Z; Dong Z; Li J; Carr MJ; Zhuang D; Wang J; Zhang Y; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hand, foot and mouth disease associated with Coxsackievirus A10 infections in Xiamen, China in 2015.
    Chen M; He S; Yan Q; Xu X; Wu W; Ge S; Zhang S; Chen M; Xia N
    J Clin Virol; 2017 Aug; 93():20-24. PubMed ID: 28577423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
    Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
    Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.